Shuttle Pharmaceuticals Holdings, Inc. Ratios

Ratios Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 2,454.12%329.94%265.39%738.84%
EBIT Margin 3,712.68%278.28%237.20%642.02%
EBITDA Margin 3,712.68%278.28%237.20%642.02%
Operating Margin 3,712.68%278.28%237.20%642.02%
Net Margin 2,673.64%337.68%265.39%738.84%
FCF Margin 639.73%295.30%225.43%611.25%
Leverage & Solvency
Interest Coverage Ratio -37.13-2.78-2.37-6.42
Times Interest Earned -37.13-2.78-2.37-6.42
Valuation
Enterprise Value 26.63M7.28M3.15M
Market Capitalization 26.63M7.28M3.15M
Return Ratios
Return on Sales 24.54%3.30%2.65%7.39%